Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosis

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 8104-8109

  Shehadeh, Naim ^a   Pollack, Shirly ^a   Wildbaum, Gizi ^a   Zohar, Yaniv ^a   Shafat, Itay ^a   Makhoul, Reem ^a   Daod, Essam ^a   Hakim, Fahed ^a   Perlman, Rina ^a   Karin, Nathan ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN ANTIBODY; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUTRALIZING ANTIBODY; PANCREAS ISLET CELL ANTIBODY; BIOLOGICAL MARKER; DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; RELIABILITY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; ANTIBODY SPECIFICITY; BLOOD; CELL LINE; IMMUNOLOGY; INFANT;

ADOLESCENT; ADULT; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BIOLOGICAL MARKERS; CELL LINE; CHEMOKINE CCL3; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; HUMANS; INFANT;

EID: 67649204115     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803348     Document Type: Article

References (50)

1. Wildbaum, G., M. Nahir, and N. Karin. 2003. Beneficial autoimmunity to proinflammatory mediators restrains the consequences of self-destructive immunity. Immunity 19: 679-688.
2. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14: 397-440.
3. Wildbaum, G., S. Youssef, and N. Karin. 2000. A targeted DNA vaccine augments the natural immune response to self TNF-α and suppresses ongoing adjuvant arthritis. J. Immunol. 165: 5860-5866.
4. Castano, L., and G. S. Eisenbarth. 1990. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8: 647-679. (Pubitemid 20135642)
5. Hutchings, P., H. Rosen, L. O'Reilly, E. Simpson, S. Gordon, and A. Cooke. 1990. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 348: 639-642. (Pubitemid 120015126)
6. Kawasaki, E., H. Takino, M. Yano, S. Uotani, K. Matsumoto, Y. Takao, Y. Yamaguchi, S. Akazawa, and S. Nagataki. 1994. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43: 80-86. (Pubitemid 24010533)
7. Pleau, J. M., F. Fernandez-Saravia, A. Esling, F. Homo-Delarche, and M. Dardenne. 1995. Prevention of autoimmune diabetes in nonobese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD 65). Clin. Immunol. Immunopathol. 76: 90-95.
8. Rudy, G., N. Stone, L. C. Harrison, P. G. Colman, P. McNair, V. Brusic, M. B. French, M. C. Honeyman, B. Tait, and A. M. Lew. 1995. Similar peptides from two β cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol. Med. 1: 625-633.
9. Atkinson, M. A. 2000. The $64000 question in diabetes continues. Lancet 356: 4-6.
10. Lohmann, T., M. Hawa, R. D. Leslie, R. Lane, J. Picard, and M. Londei. 2000. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. Lancet 356: 31-35. (Pubitemid 30416992)
11. Scofield, R. H. 2004. Autoantibodies as predictors of disease. Lancet 363: 1544-1546.
12. Sellers, E., G. Eisenbarth, T. K. Young, and H. J. Dean. 2000. Diabetes-associated autoantibodies in aboriginal children. Lancet 355: 1156.
13. Kaufman, D. L., M. G. Erlander, M. Claire-Salzler, M. A. Atkinson, N. K. Maclaren, and A. J. Tobin. 1992. Autoimmunity to two forms of glutamine decarbosylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 89: 283-292.
14. Armstrong, N. W., and D. B. Jones. 1994. Epitopes of GAD 65 in insulin-dependent diabetes mellitus. Lancet 344: 406-407. (Pubitemid 24248220)
15. Atkinson, M. A., M. A. Bowman, L. Campbell, B. L. Darrow, D. L. Kaufman, and N. K. Maclaren. 1994. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 94: 2125-2129.
16. Schatz, D., J. Krischer, G. Horne, W. Riley, R. Spillar, J. Silverstein, W. Winter, A. Muir, D. Derovanesian, S. Shah, et al. 1994. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J. Clin. Invest. 93: 2403-2407.
17. Vardi, P., S. A. Dib, M. Tuttleman, J. E. Connelly, M. Grinbergs, A. Radizabeh, W. J. Riley, N. K. Maclaren, G. S. Eisenbarth, and J. S. Soeldner. 1987. Competitive insulin autoantibody assay: prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes 36: 1286-1291.
18. Zlotnic, A., and O. Yoshei. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127.
19. Mackay, C. R. 2001. Chemokines: immunology's high impact factors. Nat. Immunol. 2: 95-101.
20. Rollins, B. J. 1997. Chemokines. Blood 90: 909-928.
21. Proudfoot, A. E. 2002. Chemokine receptors: a multifaceted therapeutic targets. Nat. Rev. Immunol. 2: 106-115.
22. Christen, U. 2007. Chemokines as drug targets in type 1 diabetes. Endocr. Metab. Immune Disord. Drug Targets 7: 7-12.
23. Christen, U., D. B. McGavern, A. D. Luster, M. G. von Herrath, and M. B. Oldstone. 2003. Among CXCR3 chemokines, IFN-γ-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-γ (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J. Immunol. 171: 6838-6845. (Pubitemid 37532119)
24. Frigerio, S., T. Junt, B. Lu, C. Gerard, U. Zumsteg, G. A. Hollander, and L. Piali. 2002. β Cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat. Med. 8: 1414-1420.
25. Cameron, M. J., G. A. Arreaza, M. Grattan, C. Meagher, S. Sharif, M. D. Burdick, R. M. Strieter, D. N. Cook, and T. L. Delovitch. 2000. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J. Immunol. 165: 1102-1110.
26. Palacios, I., M. J. Lopez-Armada, P. Hernandez, O. Sanchez-Pernaute, S. Gutierrez, R. Miguelez, J. Martinez, J. Egido, and G. Herrero-Beaumont. 1998. Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells. Clin. Exp. Immunol. 111: 588-596.
27. Bradley, L. M., V. C. Asensio, L. K. Schioetz, J. Harbertson, T. Krahl, G. Patstone, N. Woolf, I. L. Campbell, and N. Sarvetnick. 1999. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J. Immunol. 162: 2511-2520.
28. Szalai, C., A. Csaszar, A. Czinner, T. Szabo, P. Panczel, L. Madacsy, and A. Falus. 1999. Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus. Pediatr. Res. 46: 82-84. (Pubitemid 29293901)
29. Boitard, C., E. Bonifacio, G. F. Bottazzo, H. Gleichmann, and J. Molenaar. 1988. Immunology and Diabetes Workshop: report on the Third International (Stage 3) Workshop on the Standardisation of Cytoplasmic Islet Cell Antibodies: Held in New York, New York, October 1987. Diabetologia 31: 451-452.
30. Karjalainen, J., P. Salmela, J. Ilonen, H. M. Surcel, and M. Knip. 1989. A comparison of childhood and adult type I diabetes mellitus. N. Engl. J. Med. 320: 881-886. (Pubitemid 19101591)
31. Leman, E. S., R. E. Schoen, J. L. Weissfeld, G. W. Cannon, L. J. Sokoll, D. W. Chan, and R. H. Getzenberg. 2007. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers. Cancer Res. 67: 5600-5605.
32. Brennan, A. L., D. M. Geddes, K. M. Gyi, and E. H. Baker. 2004. Clinical importance of cystic fibrosis-related diabetes. J. Cyst. Fibros. 3: 209-222.
33. Bismuth, E., K. Laborde, P. Taupin, G. Velho, V. Ribault, F. Jennane, E. Grasset, I. Sermet, J. de Blic, G. Lenoir, and J. J. Robert. 2008. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J. Pediatr. 152: 540-545.
34. Youssef, S., G. Wildbaum, G. Maor, N. Lanir, A. Gour-Lavie, N. Grabie, and N. Karin. 1998. Long-lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines. J. Immunol. 161: 3870-3879.
35. Salomon, I., N. Netzer, G. Wildbaum, S. Schif-Zuck, G. Maor, and N. Karin. 2002. Targeting the function of IFN-γ-inducible protein 10 suppresses ongoing adjuvant arthritis. J. Immunol. 169: 2685-2693.
36. Wildbaum, G., N. Netzer, and N. Karin. 2002. Plasmid DNA encoding IFN-γ-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis. J. Immunol. 168: 5885-5892.
37. Goldberg, R., G. Wildbaum, Y. Zohar, G. Maor, and N. Karin. 2004. Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27. J. Immunol. 173: 1171-1178. (Pubitemid 38924293)
38. Manczak, M., S. Jiang, B. Orzechowska, and G. Adamus. 2002. Crucial role of CCL3/MIP-1α in the recurrence of autoimmune anterior uveitis induced with myelin basic protein in Lewis rats. J. Autoimmun. 18: 259-270.
39. dos Santos, A. C., M. M. Barsante, R. M. Arantes, C. C. Bernard, M. M. Teixeira, and J. Carvalho-Tavares. 2005. CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis: an intravital microscopy study. J. Neuroimmunol. 162: 122-129.
40. Badolato, R., A. N. Ponzi, M. Millesimo, L. D. Notarangelo, and T. Musso. 1997. Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood 90: 2804-2809.
41. Karpus, W. J., and K. J. Kennedy. 1997. MIP-1α and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. Leukocyte Biol. 62: 681-687.
42. Plater-Zyberk, C., A. J. Hoogewerf, A. E. Proudfoot, C. A. Power, and T. N. Wells. 1997. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol. Lett. 57: 117-120.
43. Qin, S., J. B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, A. E. Koch, B. Moser, and C. R. Mackay. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101: 746-754.
44. Barnes, D. A., J. Tse, M. Kaufhold, M. Owen, J. Hesselgesser, R. Strieter, R. Horuk, and H. D. Perez. 1998. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J. Clin. Invest. 101: 2910-2919.
45. Youssef, S., G. Maor, G. Wildbaum, N. Grabie, A. Gour-Lavie, and N. Karin. 2000. C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis. J. Clin. Invest. 106: 361-371. (Pubitemid 30655636)
46. Pierer, M., J. Rethage, R. Seibl, R. Lauener, F. Brentano, U. Wagner, H. Hantzschel, B. A. Michel, R. E. Gay, S. Gay, and D. Kyburz. 2004. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J. Immunol. 172: 1256-1265.
47. Goser, S., R. Ottl, A. Brodner, T. J. Dengler, J. Torzewski, K. Egashira, N. R. Rose, H. A. Katus, and Z. Kaya. 2005. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1α in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 112: 3400-3407.
48. Ohta, M., Y. Kitadai, S. Tanaka, M. Yoshihara, W. Yasui, N. Mukaida, K. Haruma, and K. Chayama. 2002. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int. J. Cancer 102: 220-224.
49. Ogata, H., M. Takeya, T. Yoshimura, K. Takagi, and K. Takahashi. 1997. The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats. J. Pathol. 182: 106-114.
50. Hanifi-Moghaddam, P., S. Kappler, J. Seissler, S. Muller-Scholze, S. Martin, B. O. Roep, K. Strassburger, H. Kolb, and N. C. Schloot. 2006. Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus. Diabet. Med. 23: 156-163.